B Riley shares plunge after short seller Wolfpack Research takes aim



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-B Riley shares plunge after short seller Wolfpack Research takes aim</title></head><body>

Updates shares

Feb 8 (Reuters) -Shares of investment bank B Riley Financial Inc RILY.O fell about 11% on Wednesday after Wolfpack Research disclosed a short position in the sole book-runner for troubled home goods retailer Bed Bath & Beyond Inc's BBBY.O $225 million equity offering.

The Los Angeles-based bank had overleveraged to buy speculative assets during the "financial mania" of 2020-21 when the Federal Reserve's loose monetary policy triggered a wave of risky bets, and lent money to companies that have "degenerated into zombies," the short seller alleged.

B Riley's shares fell nearly 11% to $39.31 in morning trade, the biggest intraday percentage decline in more than three months.

The company did not immediately respond to a Reuters request for comment.

Wolfpack said B Riley was not cutting losses on "failing" investments and had continued extending more capital to its distressed clients, including cryptocurrency mining company Core Scientific Inc CORZ.O that filed for bankruptcy in December.

"RILY's biggest risk is that much of its loan book appears headed for bankruptcy," Wolfpack said.

B Riley's client Bed Bath & Beyond Inc is hoping to avoid bankruptcy with the latest equity offering.

The bank's balance sheet will take a $175 million hit in the second quarter if B. Riley's special purpose acquisition company (SPAC) is liquidated, the short seller added.

The SPAC, B Riley Principal 250 Merger Corp, raised $150 million when it went public in May 2021. SPACs typically have two years to acquire a target.




Reporting by Niket Nishant in Bengaluru; Editing by Maju Samuel and Shinjini Ganguli

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.